High-Precision Lactate Dehydrogenase (LDH) Isoenzymes Kit for Serum Analysis – Electrophoresis-Based Diagnostic & Research Tool with 10-Day TAT
د.إ950.00Sample Type : Serum
Methodology : Electrophoresis
TAT : 10 Days
Showing 10–18 of 22 results
Sample Type : Serum
Methodology : Electrophoresis
TAT : 10 Days
Sample Type : Serum
Methodology : Nephelometry
TAT : 15 Days
The Oncomine Acute Myeloid Leukaemia (AML) Panel is a targeted next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of AML. It enables simultaneous detection of key mutations, gene fusions, and copy number variations across clinically relevant genes associated with AML.
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.
Sample Type : Serum
Methodology : Immunoturbidometry
TAT : 10 Days
The PD-L1 (22C3) Dako CPS (IHC) test is an immunohistochemistry (IHC) assay designed to assess PD-L1 expression in tumor and immune cells using the Combined Positive Score (CPS). It is FDA-approved as a companion diagnostic for multiple cancer therapies, ensuring precise patient selection for immune checkpoint inhibitors. The test utilizes the 22C3 monoclonal antibody, providing high sensitivity and specificity in detecting PD-L1 expression. Its standardized scoring system (CPS) enhances reproducibility and clinical decision-making, making it a trusted tool for oncologists. The Dako platform ensures consistent, high-quality staining, supporting accurate and reliable results for personalized cancer treatment.
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 10 Days
Sample Type : 24 Hour Urine
Methodology : Spectrophotometry
TAT : 1 Day
Sample Type : Whole Blood
Methodology : Spectrophotometry
TAT : 10 Days